JANUARY 8, 2021 Ajinomoto Cambrooke, Inc. hosted an online seminar, on December 19, 2020, for our distribution partner in China, as well as for local PKU patients. The focus was to provide the benefits of Glycomacropeptide (GMP) and our products made from it. Since the acquisition by Ajinomoto, Cambrooke has been exploring an opportunity…
Press Release: Cycle Pharmaceuticals Launches Free Trial of NITYR in the US and Partners with Cambrooke Therapeutics to Support HT-1 Patients’ Dietary Needs. read more
New evidence – Glytactin supports bone health. read article Download clinical study
AYER, Mass–Cambrooke Therapeutics Inc., a leader in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, announces the launch of Tylactin™ COMPLETE Bars, a nutritionally complete medical food, available in a convenient portable format, for the dietary management of Tyrosinemia (TYR). Tylactin with GMP is made from a natural whole protein derived from…
AYER, Mass.–(BUSINESS WIRE)–Cambrooke Therapeutics Inc., an innovation leader in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, launches the long awaited baking mix, KetoVie Café Kwik Mix 4.5:1, to its popular line of a ketogenic foods. KetoVie Café Kwik Mix 4.5:1 is easy to use and has the versatility to make a…
AYER, Mass.–(BUSINESS WIRE)–Cambrooke Therapeutics Inc., a leader in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, announces the launch of Tylactin™ RESTORE Powder, a medical food hydration beverage, available in convenient portable single-serve stick-packs for the dietary management of Tyrosinemia (TYR). Tylactin with GMP is made from a natural whole protein derived…
AYER, Mass.–(BUSINESS WIRE)–Cambrooke Therapeutics Inc., a leader in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, announces the introduction of Glytactin BUILD, a unique medical food formula for the dietary management of Phenylketonuria (PKU). This latest addition to the glytactin family of PKU products was designed to enhance availability of the specialized…
AYER, Mass.–(BUSINESS WIRE)–Cambrooke Therapeutics Inc., a leader in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, is pleased to announce a new and improved Glytactin Complete Bar, a Medical Food for the dietary management of Phenylketonuria (PKU). The new and improved Glytactin Complete Bar contains glytactin with glycomacropeptide (GMP) with all the…
SEPTEMBER 9, 2016 AYER, Mass.–Cambrooke Therapeutics Inc., a leader in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, announces the launches of Glytactin RESTORE Powder™ and Glytactin RESTORE Lite Powder™, two medical food hydration beverages offered in convenient, portable, single-serve, stick-packs for the dietary management of Phenylketonuria (PKU). Glytactin with GMP is…
We use cookies on our websites in order to ensure that our websites work well, enhance your experience on our websites, and analyze use of our websites. Please click “Agree” to consent to our use of cookies. Read more about our Privacy Policy.
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
